Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 2.782
1.
Am J Case Rep ; 25: e943098, 2024 May 13.
Article En | MEDLINE | ID: mdl-38736220

BACKGROUND Sinonasal rhabdomyosarcoma (RMS) is a rare malignancy in children and adolescents. It is aggressive and locally invasive, and can require local postoperative radiotherapy. This report presents the case of a 16-year-old girl with a sinonasal-cutaneous fistula following excision and radiotherapy for rhabdomyosarcoma, which required reconstructive surgery using an expanded forehead flap. CASE REPORT We report the case of a16-year-old girl who was referred to our clinic with sinonasal-cutaneous fistula. Prior to presentation at our department, she presented with bilateral intermittent nasal congestion 3 years ago. At a local hospital, orbital computed tomography and nasal endoscopic biopsy revealed an embryonal rhabdomyosarcoma (ERMS). One month later, skull base tumor resection, nasal cavity and sinus tumor resection, and low-temperature plasma ablation were performed at a local hospital. Two weeks after the operation, the patient received intensity-modulated radiation therapy for a total of 50 Gy. Chemotherapy started 15 days after radiotherapy, using a vincristine, dactinomycin, and cyclophosphamide (VAC) regimen. Approximately 1 month later, an ulcer appeared at the nasal root and the lesion gradually expanded. The patient was referred to our hospital due to the defect. Firstly, a tissue expander was implanted at the forehead for 7 months. Then, the skin around the defect was trimmed and forehead flap was separated to repair the lining and external skin. The flap survived well 1-year after the operation. CONCLUSIONS This report highlights the challenges of post-radiation reconstructive surgery and describes how an expanded forehead flap can achieve an acceptable cosmetic outcome in a patient with a sinonasal-cutaneous fistula.


Cutaneous Fistula , Forehead , Surgical Flaps , Humans , Female , Adolescent , Cutaneous Fistula/etiology , Cutaneous Fistula/surgery , Plastic Surgery Procedures/methods , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/radiotherapy , Rhabdomyosarcoma/surgery , Rhabdomyosarcoma/radiotherapy , Rhabdomyosarcoma, Embryonal/surgery , Rhabdomyosarcoma, Embryonal/radiotherapy , Nose Neoplasms/surgery , Nose Neoplasms/radiotherapy , Postoperative Complications
2.
Sci Prog ; 107(2): 368504241253679, 2024.
Article En | MEDLINE | ID: mdl-38720572

OBJECTIVES: To present a case report of sinonasal glomangiopericytoma (GPC) in a female patient in her thirties and to highlight the importance of collecting pathology specimens even in routine sinus surgery cases. METHODS: A case report detailing the diagnosis of GPC in a female in her thirties, including her initial presentation, treatment, and follow-up, along with a brief review of the literature. RESULTS: Pathology of the collected specimen revealed sinonasal GPC along with chronic rhinosinusitis. Immunohistochemistry was positive for SMA, beta-catenin, and cyclin D1; and negative for STAT6, ERG, pankeratin, SOX10, and S100. CONCLUSION: This diagnosis expands the knowledge around the demographic profile of GPC patients. GPC should be included in the differential diagnosis of sinonasal masses, even in younger patients. The case highlights the importance of collecting the entire pathology specimen in all cases, even of ones that seem routine and benign.


Hemangiopericytoma , Humans , Female , Hemangiopericytoma/pathology , Hemangiopericytoma/diagnosis , Hemangiopericytoma/surgery , Adult , Paranasal Sinus Neoplasms/pathology , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/diagnosis , Immunohistochemistry
3.
Acta Otorhinolaryngol Ital ; 44(2): 128-137, 2024 Apr.
Article En | MEDLINE | ID: mdl-38651554

Objective: Endoscopic endonasal surgery is effective in the treatment of sinonasal cancers. However, in cases of well-differentiated locally advanced neoplasms as well as recurrences, the most appropriate treatment is debated. The purpose of this study is to report a mono-institutional experience on craniofacial surgery performed in a tertiary-care referral centre. Methods: This was a retrospective analysis of 90 patients treated with transcranial and/or transfacial resection for sinonasal cancer between 2010 and 2020. Outcome measures included overall survival (OS), disease-specific survival (DSS), disease-free survival (DFS) and recurrence-free survival (RFS). Results: The 5-year OS, DSS and DFS were 48.2%, 60.6% and 28.7%, respectively. Factors correlated with prognosis were pT-classification (p = 0.002), histotype (p = 0.012) and dural involvement (p = 0.004). Independent prognostic factors were orbital apex infiltration (p = 0.03), age (p = 0.002) and adjuvant therapy (p = 0.03). Conclusions: When endoscopic endonasal surgery is contraindicated and chemoradiotherapy is not appropriate, craniofacial and transfacial approaches still represent an option to consider, despite the non-negligible morbidity.


Paranasal Sinus Neoplasms , Humans , Male , Female , Retrospective Studies , Middle Aged , Aged , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/mortality , Adult , Aged, 80 and over , Endoscopy/methods , Time Factors , Survival Rate , Treatment Outcome , Neoplasm Staging , Prognosis
4.
J Cancer Res Ther ; 20(1): 485-487, 2024 Jan 01.
Article En | MEDLINE | ID: mdl-38554372

Leimyosarcoma (lms) is a malignant soft tissue tumor of smooth muscles. The tumor arises intramuscularly and in subcutaneous locations. It is unusual to encounter lms in head and neck region, even more infrequent to discover lms in nasal and paranasal sinuses. A case of 28 years old male with leiomyosarcoma originating from sphenoid sinus with intracranial extension is being presented with aim to highlight its rarity and to highlight the differential diagnosis and the need for prudent diagnosis in the work-up of the patient.


Leiomyosarcoma , Paranasal Sinus Neoplasms , Paranasal Sinuses , Humans , Male , Adult , Sphenoid Sinus/diagnostic imaging , Sphenoid Sinus/pathology , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/surgery , Leiomyosarcoma/diagnosis , Leiomyosarcoma/surgery , Leiomyosarcoma/pathology , Paranasal Sinuses/pathology , Diagnosis, Differential
5.
HNO ; 72(4): 257-264, 2024 Apr.
Article De | MEDLINE | ID: mdl-38214715

Inverted papilloma (IP) are benign tumors that show a locally aggressive behavior, a high rate of recurrence, and a potential for malignant transformation. Specific radiological signs such as hyperostosis at the origin of the IP and convoluted cerebriform patterns, as well as the typical endoscopic aspect, can lead to diagnosis and enable preoperative planning of surgical access and the extent of surgery. Endonasal endoscopic techniques are considered the gold standard and the introduction of extended surgical techniques such as the prelacrimal approach, frontal drillout, or orbital transposition facilitate complete subperiosteal resection with preservation of important physiological structures. There is a risk of synchronous and metachronous squamous cell carcinomas (IP-SCC). Research focuses on radiological criteria to differentiate benign IP from IP-SCC, genetic and epigenetic factors in the process of malignant transformation, and estimation of the risk of IP progressing to IP-SCC.


Nose Neoplasms , Papilloma, Inverted , Paranasal Sinus Neoplasms , Paranasal Sinuses , Humans , Papilloma, Inverted/diagnosis , Papilloma, Inverted/surgery , Paranasal Sinus Neoplasms/diagnosis , Paranasal Sinus Neoplasms/surgery , Paranasal Sinuses/pathology , Nose/pathology , Tomography, X-Ray Computed , Nose Neoplasms/diagnosis , Nose Neoplasms/surgery , Nose Neoplasms/pathology , Retrospective Studies
6.
Eur Arch Otorhinolaryngol ; 281(6): 2993-3004, 2024 Jun.
Article En | MEDLINE | ID: mdl-38228884

PURPOSE: Intestinal-type adenocarcinoma (ITAC) is a rare sinonasal malignancy. Curative treatment requires multidisciplinary approach, with surgical options consist of the endonasal endoscopic approach (EEA) and external surgery (EXTS). Here, we provide the post-operative and survival results from a single-center long-term follow-up. METHODS: We report long-term follow-up of 92 ITAC cases treated between 1998 and 2018, treated with EEA (n = 40) or EXTS (n = 52). Survival estimates, post-operative complications and duration of hospitalization were compared between surgical modalities. RESULTS: Baseline characteristics were similar. A higher number of T4b tumors (16%), and subsequently more tumoral invasion (39%), was present in patients undergoing EXTS compared to EEA (3% and 18%, respectively). No difference in Barnes histology subtypes was noticed. Patients undergoing EEA had a shorter post-operative hospitalization stay versus EXTS (4 versus 7 days). Use of EEA was associated to improved disease-specific survival (DSS; 11.4 versus 4.4 years; HREEA = 0.53), especially for patients with T3-4a tumors (11.4 versus 3.0 years; HREEA = 0.41). Patients with T3-4 stage, tumoral invasion, positive surgical margins, mucinous or mixed histology, and prolonged post-operative hospital stay showed poor local relapse-free, disease-free, overall, and DSS. CONCLUSIONS: Long-term follow-up in locally advanced ITAC demonstrates that resection by EEA is correlated with improved DSS compared to EXTS, especially for T3-4 tumors. No significant differences between both treatment modalities was observed regarding per- and post-operative complications, although hospitalization in patients undergoing EEA was shorter than for patients treated with EXTS. These results confirm that EEA should remain the preferred surgical procedure in operable cases of sinonasal ITAC.


Adenocarcinoma , Paranasal Sinus Neoplasms , Humans , Male , Female , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/pathology , Paranasal Sinus Neoplasms/mortality , Adenocarcinoma/surgery , Adenocarcinoma/pathology , Adenocarcinoma/mortality , Middle Aged , Aged , Follow-Up Studies , Postoperative Complications/epidemiology , Retrospective Studies , Length of Stay/statistics & numerical data , Adult , Endoscopy/methods , Survival Rate , Neoplasm Staging
7.
Am J Otolaryngol ; 45(2): 104129, 2024.
Article En | MEDLINE | ID: mdl-38070378

INTRODUCTION: Inverted papillomas (IP) are benign epithelial tumors with a tendency to be locally invasive and with disposition to recur. The aim of our study is to present the results of IP treatment, considering pathological, immunohistochemical and molecular features of recurrence. MATERIAL AND METHODS: From 1978 to 2020, 186 sinonasal IPs surgeries corresponding to 152 patients were treated in our center. We performed a pathology evaluation of all the recurrent cases reviewing the histological diagnosis, the presence of mixed component other than IP, the koilocytic changes, the p16 over expression and HPV-DNA detection. RESULTS: Overall recurrence rate was 19 % (35/186). The 35 IP recurrences correspond to 22 patients, 9 of whom presented a single recurrence (single recurrence group) while 13 of them presented more than one recurrence (multi-recurrent group). Immunohistochemical analysis showed a higher percentage of p16 overexpression (54 % vs 33 % p = 0.415) and HPV-DNA presence (23 % vs 0 % p = 0.240) in the multi-recurrent group compared with single recurrence group. In addition, the revision showed more IP with exophytic papilloma focus (38 vs 22 % p = 0.648) and a higher proportion of IP with koilocytotic changes (61 % vs 22 % p = 0.099) in the multirecurrent group. There is no significant difference between groups in our results. CONCLUSION: The analysis of our patients may differentiate between two groups with recurrent papillomas. A single recurrence group where the cause of recurrence is probably an anatomical problem related to an incomplete resection, and a second pattern, the multi-recurrence group, where HPV infection may be the main cause of recurrence.


Nose Neoplasms , Papilloma, Inverted , Papillomavirus Infections , Paranasal Sinus Neoplasms , Respiratory Tract Neoplasms , Humans , Papilloma, Inverted/surgery , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/pathology , Papillomavirus Infections/surgery , Papillomavirus Infections/pathology , Retrospective Studies , Nose Neoplasms/surgery , DNA , Papillomaviridae/genetics
8.
Laryngoscope ; 134(3): 1308-1312, 2024 Mar.
Article En | MEDLINE | ID: mdl-37606271

A 35-year-old female with an extensive biphenotypic sinonasal sarcoma (BSNS) eroding through the left frontal sinus into the orbit required gross total resection of the tumor. We wanted to forgo an open approach and provide a less invasive alternative via combined endonasal and transorbital endoscopic techniques to allow for tumor removal through small, well-disguised incisions. We utilized three portals-nasal, transorbital, and anterior table window-to create interconnected orbit-sinonasal corridors, thus generating alternate pathways for visualization and manipulation of this extensive tumor. Laryngoscope, 134:1308-1312, 2024.


Paranasal Sinus Neoplasms , Surgical Wound , Female , Humans , Adult , Endoscopy/methods , Nose , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/surgery , Orbit/surgery
9.
Head Neck ; 46(3): E32-E39, 2024 Mar.
Article En | MEDLINE | ID: mdl-38088461

BACKGROUND: Sinonasal carcinomas represent a rare group of malignancies, accounting for less than 5% of all head and neck cancers and a worldwide incidence of less than 1 case per 100 000 inhabitants annually. Despite the restricted anatomical location, sinonasal carcinomas harbor some of the most histologically and molecularly diverse groups of tumors. SMARCB1 (INI1)-deficient sinonasal carcinomas are locally aggressive tumors commonly detected late, leading to devastating morbidity and mortality. CASE REPORT: We present two cases of SMARCB1-deficient sinonasal carcinoma involving the oral cavity and presenting as progressive radiolucent lesions with local swelling associated with maxillary dentition and alveolar bone. Both cases were initially considered odontogenic in origin and involved the destruction of the left anterior maxilla. CONCLUSION: Given the rarity and the variable presentation of these tumors, they pose a challenge for head and neck surgeons, dentists, and pathologists due to the potential overlapping features with odontogenic and non-odontogenic inflammatory and neoplastic lesions. These cases highlight the importance of a multidisciplinary team and include SMARCB1-deficient sinonasal carcinomas in the differential diagnosis of destructive lesions of the maxilla.


Carcinoma , Paranasal Sinus Neoplasms , Humans , Biomarkers, Tumor , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/genetics , Paranasal Sinus Neoplasms/surgery , Carcinoma/genetics , Carcinoma/pathology , SMARCB1 Protein/genetics
10.
Laryngoscope ; 134(4): 1591-1596, 2024 Apr.
Article En | MEDLINE | ID: mdl-37767874

OBJECTIVE: To analyze clinical and radiographic features that may impact the rate of focal hyperostosis (FH) on computed tomography (CT) for primary and recurrent sinonasal inverted papillomas (IPs) as well as highlight factors that may affect concordance between FH and IP true attachment point (TAP). METHODS: All IPs resected between 2006 and 2022 were retrospectively reviewed. CTs were read by a neuroradiologist blinded to operative details. IP with malignancy was excluded. Operative reports and long-term follow-up data were evaluated. RESULTS: Of 92 IPs, 60.1% had FH, 25% had no CT bony changes, and 20.7% were revision cases. The recurrence rate for rhinologists was 10.5% overall and 7.3% for primary IPs. Primary and revision IPs had a similar rate of FH (63% vs. 52.6%; p = 0.646) and FH-TAP agreement (71.7% vs. 90%; p = 0.664). Nasal cavity IPs, especially with septal attachment, were more likely to lack bony changes on CT (57.1%) compared to other subsites (p = 0.018). Recurrent tumors were 16 mm larger on average (55 mm vs. 39 mm; p = 0.008). FH (75.0% vs. 60.9%; p = 0.295), FH-TAP concordance (91.7% vs. 74.4%; p = 0.094), and secondary IP (18.8% vs. 20.3%; p = 0.889) rates were similar between recurrent and nonrecurrent tumors. CONCLUSION: Primary and revision IPs have a similar rate of FH and FH-TAP agreement. Nasal cavity IPs are less likely to exhibit bony CT changes. Lower recurrence was associated with smaller size and fellowship training but not multiple TAPs, revision, FH absence, or FH-TAP discordance. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:1591-1596, 2024.


Nose Neoplasms , Papilloma, Inverted , Paranasal Sinus Neoplasms , Humans , Papilloma, Inverted/diagnostic imaging , Papilloma, Inverted/surgery , Papilloma, Inverted/pathology , Nose Neoplasms/diagnostic imaging , Nose Neoplasms/surgery , Nose Neoplasms/pathology , Retrospective Studies , Magnetic Resonance Imaging , Neoplasm Recurrence, Local/diagnostic imaging , Neoplasm Recurrence, Local/surgery , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/pathology , Tomography, X-Ray Computed
11.
Laryngoscope ; 134(4): 1633-1637, 2024 Apr.
Article En | MEDLINE | ID: mdl-37676076

Frontal sinus surgery still represents a challenge due to its complex and highly variable anatomy. In this manuscript, we present a detailed anatomical description of an eyebrow approach that allows full exposure of the frontal sinus with a large osteoplastic bone flap and preservation of the supraorbital nerve. Laryngoscope, 134:1633-1637, 2024.


Frontal Sinus , Paranasal Sinus Neoplasms , Plastic Surgery Procedures , Humans , Frontal Sinus/surgery , Eyebrows , Paranasal Sinus Neoplasms/surgery , Orbit/surgery
12.
Int Forum Allergy Rhinol ; 14(3): 720-723, 2024 Mar.
Article En | MEDLINE | ID: mdl-37548133

KEY POINTS: Narrow-band imaging (NBI) can be used to differentiate benign sinonasal lesions NBI can be used in the preoperative identification of sinonasal inverted papilloma Future studies can focus on NBI for recurrent inverted papilloma and surgical margin guidance.


Nose Neoplasms , Papilloma, Inverted , Paranasal Sinus Neoplasms , Humans , Papilloma, Inverted/diagnostic imaging , Papilloma, Inverted/surgery , Endoscopy/methods , Nose Neoplasms/diagnostic imaging , Nose Neoplasms/surgery , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/pathology
13.
Eur Arch Otorhinolaryngol ; 281(2): 785-794, 2024 Feb.
Article En | MEDLINE | ID: mdl-37733092

PURPOSE: The Nordic countries (27 M) all have comparable, publicly funded healthcare systems, and the management of sinonasal tumours is centralised to the 21 university hospitals. We sought to assess and compare the treatment practice of sinonasal tumours across the Nordic countries. METHODS: A web-based questionnaire was sent to all university hospital departments of otorhinolaryngology-head and neck surgery in the Nordic countries. RESULTS: Answers were obtained from all 21 Nordic university hospitals. The endoscopic approach was widely utilised by all, with most (62%) centres reporting 3-4 surgeons performing endoscopic sinonasal tumour surgery. Finland reported the lowest rates of centralisation among university hospitals despite having the highest number of 0.1-1 M catchment population hospitals. Most centres (88%) opted for the endoscopic approach in a patient case warranting medial maxillectomy. In a case of a Kadish C esthesioneuroblastoma, most (52%) of the centres preferred an endoscopic approach. Most centres (62%) reported favouring the endoscopic approach in a case describing a juvenile angiofibroma. Regarding a case describing a sinonasal undifferentiated carcinoma, consensus was tied (38% vs. 38%) between endoscopic resection followed by postoperative (chemo)radiotherapy (RT/CRT) and induction chemotherapy followed by RT/CRT or surgery followed by RT/CRT. CONCLUSION: Endoscopic approach was widely utilised in the Nordic countries. The case-based replies showed differences in treatment practice, both internationally and nationally. The rate of centralisation among university hospitals remains relatively low, despite the rarity of these tumours.


Head and Neck Neoplasms , Maxillary Sinus Neoplasms , Paranasal Sinus Neoplasms , Paranasal Sinuses , Humans , Endoscopy , Hospitals, University , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/pathology , Paranasal Sinuses/pathology , Surveys and Questionnaires
14.
Am J Otolaryngol ; 45(2): 104133, 2024.
Article En | MEDLINE | ID: mdl-38039908

OBJECTIVES: To evaluate the impact of facility volume on outcomes following primary endoscopic surgical management of sinonasal squamous cell carcinoma (SNSCC). METHODS: The 2010-2016 National Cancer DataBase (NCDB) was queried for patients diagnosed with T1-T4a SNSCC surgically treated endoscopically as the primary treatment modality. Factors associated with overall survival (OS) were evaluated, including facility volume. RESULTS: A total of 330 patients who underwent endoscopic surgical management of SNSCC were treated at 356 unique facilities designated as either low-volume (LVC; treating 1-2 cases; 0-75th percentile), intermediate-volume centers (IVC; 3-4 cases total; 75th-90th percentile), or 144 high-volume (HVC; treating 5+ cases total; >90th percentile) centers. HVC treated patients with higher T staging (42.1 % vs. 29.8 %) and tumors in the maxillary sinus (26.9 % vs. 13.2 %) and ethmoid sinus (10.3 % vs. ≤8.3 %), while LVCs treated lower T stage tumors (70.2 % vs. 57.9 %) and tumors that were located in the nasal cavity (70.2-78.5 % vs. 62.8 %). On multivariable analysis, factors associated with decreased OS included higher T stage (T3/T4a vs. T1/T2; OR 1.92, 95 % CI 1.06-3.47) and older age (>65 vs. <65; OR 2.69, 95 % CI 1.62-4.49). Cases treated at high-volume centers were not associated with a higher likelihood of OS when compared to low-volume centers (OR 0.70, 95 % CI 0.36-1.35). CONCLUSIONS: HVC are treating more primary tumors of the maxillary and ethmoid sinuses and tumors with higher T stages with endoscopic approaches, although this does not appear to be associated with increased OS. SHORT SUMMARY: Sinonasal squamous cell carcinoma (SNSCC) presents late in disease process with poor prognosis. We investigated the impact of facility volume on outcomes following endoscopic treatment of SNSCC. High-volume centers treat more advanced and complex disease with comparable OS.


Carcinoma, Squamous Cell , Paranasal Sinus Neoplasms , Humans , Carcinoma, Squamous Cell/pathology , Squamous Cell Carcinoma of Head and Neck , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/pathology , Nasal Cavity/pathology , Ethmoid Sinus/surgery , Retrospective Studies
16.
Oral Oncol ; 147: 106619, 2023 Dec.
Article En | MEDLINE | ID: mdl-37925895

Sinonasal organizing hematomas (SOH) are rare, benign lesions that can be mistaken for malignancies due to their unfamiliarity among clinicians and aggressive appearance on imaging, which can lead to aggressive and unnecessary therapeutic interventions. Herein, we report an unusual case of SOH in an 87-year-old female patient who sought care at a maxillofacial surgery service due to persistent right nasal obstruction and imaging findings that suggested the possibility of sinonasal malignancy. We highlight the importance of recognizing these lesions to ensure adequate treatment through a conservative approach.


Paranasal Sinus Neoplasms , Female , Humans , Aged, 80 and over , Paranasal Sinus Neoplasms/surgery , Tomography, X-Ray Computed/methods , Hematoma/diagnostic imaging , Hematoma/pathology , Magnetic Resonance Imaging/methods
18.
Sci Rep ; 13(1): 12439, 2023 08 02.
Article En | MEDLINE | ID: mdl-37532726

Sinonasal inverted papilloma (IP) is at risk of recurrence and malignancy, and early diagnosis using nasal endoscopy is essential. We thus developed a diagnostic system using artificial intelligence (AI) to identify nasal sinus papilloma. Endoscopic surgery videos of 53 patients undergoing endoscopic sinus surgery were edited to train and evaluate deep neural network models and then a diagnostic system was developed. The correct diagnosis rate based on visual examination by otolaryngologists was also evaluated using the same videos and compared with that of the AI diagnostic system patients. Main outcomes evaluated included the percentage of correct diagnoses compared to AI diagnosis and the correct diagnosis rate for otolaryngologists based on years of practice experience. The diagnostic system had an area under the curve of 0.874, accuracy of 0.843, false positive rate of 0.124, and false negative rate of 0.191. The average correct diagnosis rate among otolaryngologists was 69.4%, indicating that the AI was highly accurate. Evidently, although the number of cases was small, a highly accurate diagnostic system was created. Future studies with larger samples to improve the accuracy of the system and expand the range of diseases that can be detected for more clinical applications are warranted.


Papilloma, Inverted , Paranasal Sinus Neoplasms , Humans , Retrospective Studies , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/surgery , Artificial Intelligence , Endoscopy , Neoplasm Recurrence, Local/surgery
19.
Vet Radiol Ultrasound ; 64(5): E60-E63, 2023 Sep.
Article En | MEDLINE | ID: mdl-37549935

A 10-year-old female spayed Kelpie cross was presented to The Austin Vet Specialists for further investigation of a mineralized, lobulated frontal sinus mass that had previously been detected radiographically. Computed tomography (CT) revealed a large, expansile, well-defined, heterogeneously mineral attenuating mass invading both frontal sinuses. The mass was surgically debulked via a frontal sinusotomy approach. Histopathology was consistent with ossifying fibroma. This  is the first published report to describe frontal sinus ossifying fibroma in a dog, and the second to describe CT features of ossifying fibroma involving the cranium in a dog.


Dog Diseases , Fibroma, Ossifying , Frontal Sinus , Paranasal Sinus Neoplasms , Female , Dogs , Animals , Fibroma, Ossifying/diagnostic imaging , Fibroma, Ossifying/surgery , Fibroma, Ossifying/veterinary , Frontal Sinus/diagnostic imaging , Frontal Sinus/surgery , Frontal Sinus/pathology , Paranasal Sinus Neoplasms/diagnostic imaging , Paranasal Sinus Neoplasms/surgery , Paranasal Sinus Neoplasms/veterinary , Tomography, X-Ray Computed/veterinary , Dog Diseases/diagnostic imaging , Dog Diseases/surgery , Dog Diseases/pathology
20.
Jpn J Clin Oncol ; 53(11): 1045-1050, 2023 Nov 05.
Article En | MEDLINE | ID: mdl-37551022

BACKGROUND: Head and neck mucosal melanomas are rare malignancies. Although the prognosis is poor owing to the high incidence of distant metastases, locoregional control remains important. It is difficult to obtain results in a large cohort because of its rarity. This study aimed to elucidate the survival outcomes of patients with head and neck mucosal melanoma treated with surgery in Japan. METHODS: Patients with head and neck mucosal melanoma who were surgically treated between 2007 and 2021 at the National Cancer Center Hospital were retrospectively analyzed. RESULTS: A total of 47 patients were included in this study. The 5-year overall survival, disease-specific survival, locoregional control and relapse-free survival rates were 42%, 50%, 79% and 13%, respectively. The disease-specific survival of the oral mucosal melanoma group was significantly better than that of the sinonasal mucosal melanoma group (5-year disease-specific survival rate: 70% versus 37%, respectively; P = 0.04). Multivariate analyses revealed that sinonasal mucosal melanoma were independently significant adverse prognostic factor, for overall survival and disease-specific survival. Patients with oral mucosal melanoma patients had a higher incidence of lymph node metastasis than those with sinonasal mucosal melanoma patients (P < 0.0001). CONCLUSION: This study demonstrated the survival outcomes of the largest cohort of patients with head and neck mucosal melanomas treated surgically at a single institution within the past 20 years in Japan. We found that survival outcomes and incidence of nodal metastases varied by site.


Head and Neck Neoplasms , Melanoma , Paranasal Sinus Neoplasms , Humans , Retrospective Studies , Japan/epidemiology , Neoplasm Recurrence, Local/pathology , Melanoma/surgery , Melanoma/pathology , Head , Prognosis , Paranasal Sinus Neoplasms/surgery , Head and Neck Neoplasms/surgery , Survival Rate
...